Pegylated interferon and Ribavirin are the treatment backbone for chronic hepatitis C and may favour the development of psychiatric symptoms. These adverse events may reduce treatment adherence and are a risk factor for its failure. The recent experts’ recommendations of European Association for the Study of the Liver, suggest monitoring psychiatric manifestations on a regular basis during the antiviral treatment but the frequency of psychiatric controls sometimes might be insufficient. We present a particular case of a young woman without psychiatric history, who developed different mood and behavioural disturbances during antiviral therapy, that required an intensive psychiatric monitoring and supportive psychotherapy.
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C / Simonetti, G; Vitale, G; Taruschio, G; Vukotic, R; Gamal, N; Pirillo, L; Boncompagni, G; Bernardi, M; Andreon, E.. - In: JOURNAL OF CASE REPORTS. - ISSN 2231-6809. - 4:(2014), pp. 132-135. [10.17659/01.2014.0033]
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C.
Vukotic R;Gamal N;Bernardi M;Andreone.
2014
Abstract
Pegylated interferon and Ribavirin are the treatment backbone for chronic hepatitis C and may favour the development of psychiatric symptoms. These adverse events may reduce treatment adherence and are a risk factor for its failure. The recent experts’ recommendations of European Association for the Study of the Liver, suggest monitoring psychiatric manifestations on a regular basis during the antiviral treatment but the frequency of psychiatric controls sometimes might be insufficient. We present a particular case of a young woman without psychiatric history, who developed different mood and behavioural disturbances during antiviral therapy, that required an intensive psychiatric monitoring and supportive psychotherapy.File | Dimensione | Formato | |
---|---|---|---|
Psychiatrics in HCV.pdf
Accesso riservato
Dimensione
700.27 kB
Formato
Adobe PDF
|
700.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris